South Korea - Export of Heparin for Therapeutic Use
Since 2014, South Korea Export of Heparin for Therapeutic Use rose 15% year on year. With $27,270,353.7 in 2019, the country was number 16 among other countries in Export of Heparin for Therapeutic Use. South Korea is overtaken by Israel, which was ranked number 15 at $30,176,670.87 and is followed by Russia with $18,863,686.67. China ranked the highest with $1,237,456,257.9 in 2019, a decrease of 3% compared to 2018. United States, France and Singapore respectively ranked number 2, 3 and 4 in this ranking. Montenegro witnessed the best average annual growth at +490.8% per year, while Greenland witnessed the worst performance at -78.9% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 27,270,353.70 |
| 2018 | 26,957,100.00 |
| 2017 | 21,039,252.00 |
| 2016 | 18,610,468.00 |
| 2015 | 17,223,676.00 |
Download all data from 1988 to 2019
How does South Korea rank in Export of Heparin for Therapeutic Use?
| # | 108 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
China
|
1,237,456,257.90 | 2019 | -3.0 % | +6.7 % | View data | |
| 2 |
#2
United States
|
528,184,315.05 | 2019 | +3.8 % | -15.3 % | View data | |
| 15 |
#15
Israel
|
30,176,670.87 | 2019 | +5.0 % | +134.0 % | View data | |
| 16 |
#16
South Korea
|
27,270,353.70 | 2019 | +1.2 % | +15.0 % | View data | |
| 17 |
#17
Russia
|
18,863,686.67 | 2019 | +12.0 % | +1.5 % | View data | |